News & Updates

Show Multimedia Only

Fewer migraine days with dual therapy

17 Jul 2023 by

Combination therapy with an anti-CGRP* monoclonal antibody (mAB) and onabotulinumtoxinA may be more effective than either therapy in patients with chronic migraine, according to a new study.

17 Jul 2023

Aquablation beneficial in men with urinary retention

16 Jul 2023

Aquablation therapy appears to lead to spontaneous voiding in men with urinary retention, regardless of preoperative urodynamic findings, according to a study.

16 Jul 2023

Bezlotoxumab prevents CDI recurrence in immunocompromised patients

16 Jul 2023

Treatment with bezlotoxumab results in a significant decrease in recurrent Clostridioides difficile infection (CDI) in a cohort of immunocompromised patients and transplant recipients, reports a study.

16 Jul 2023

Major malformation risk after assisted reproductive treatment higher with ICSI vs IVF

16 Jul 2023

Children conceived via fresh intracytoplasmic sperm injection (ICSI) are at higher risk of major malformations compared with those conceived via fresh in vitro fertilization (IVF), according to a study.

16 Jul 2023

Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab

15 Jul 2023

Time to recovery from COVID-19 pneumonia does not appear to differ following treatment with abatacept, cenicriviroc, or infliximab among hospitalized patients, according to a study.

15 Jul 2023

Danuglipron helps with glucose control, weight loss in T2D

15 Jul 2023 by

The glucagon-like peptide 1 receptor (GLP-1R) agonist danuglipron appears to be beneficial in the treatment of patients with type 2 diabetes (T2D), yielding reductions in glycated haemoglobin (HbA1c), fasting plasma glucose (FPG), and body weight, without fasting restrictions, as shown in the results of a phase IIb study.

15 Jul 2023

Long-acting ART induces viral suppression in people with HIV

15 Jul 2023

People with HIV (PWH) who are treated with long-acting (LA) antiretroviral therapy (ART) achieve virologic suppression, as do those with viraemia and challenges to adherence, reports a study.

15 Jul 2023

Moderate coffee intake good for the heart

15 Jul 2023

Drinking coffee in moderation may reduce the risk of heart failure incidence for adults, as reported in a study.

15 Jul 2023

Tranexamic acid of no help in reducing bleeding complications related to HoLEP

14 Jul 2023

Perioperative tranexamic acid treatment in patients undergoing holmium laser enucleation of the prostate (HoLEP) falls short of reducing the risk of a return to the operating room for bleeding, catheter reinsertion, or clotting complications, according to a study.

14 Jul 2023

Anxiety, depression jeopardize health of axSpA patients

14 Jul 2023 by

Patients with axial spondyloarthritis (axSpA) may experience a decline in their overall health and functioning due to the presence of comorbid anxiety and depression, as reported in a study from Singapore.

14 Jul 2023

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Fewer migraine days with dual therapy

Aquablation beneficial in men with urinary retention

Bezlotoxumab prevents CDI recurrence in immunocompromised patients

Major malformation risk after assisted reproductive treatment higher with ICSI vs IVF

Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab

Danuglipron helps with glucose control, weight loss in T2D

Long-acting ART induces viral suppression in people with HIV

Moderate coffee intake good for the heart

Tranexamic acid of no help in reducing bleeding complications related to HoLEP

Anxiety, depression jeopardize health of axSpA patients